MustGrow Biologics to Present at the Planet MicroCap Showcase
19 April 2024, Canada: MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the “Company” or “MustGrow”) is pleased to announce it will be presenting
Read More
MustGrow
MustGrow Receives Registration Approval for TerraSanteᵀᴹ in Oregon
07 February 2024, Canada: MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of The
Read More
MustGrow Provides Additional Information and Clarification on Commercial License Agreement with Bayer
15 December 2023, Canada: MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (“MustGrow”) wishes to provide additional information about the collaboration agreement (the “Agreement”)
Read More
MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa
12 December 2023, Canada: MustGrow Biologics Corp. has announced the signing of a collaboration agreement with Bayer AG covering soil applications of
Read More
MustGrow to Present at the Harbor Access Global SMID Cap Investor Conference November 16th
The Company invites market participants to attend in online at VirtualInvestorConferences.com 11 November 2023, Canada: MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the “Company”
Read More
MustGrow Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program
08 November 2023, Canada: MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the “Company” or “MustGrow”) is pleased to announce the approval of Health Canada’s Pest
Read More
MustGrow Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology
01 November 2023, Canada: MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of organic compliance
Read More
MustGrow Announces Investor Relations Agreement with Harbor Access
13 September 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”) is pleased to announce the
Read More
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion
07 September 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division
Read More
MustGrow Announces Grant of RSUs and DSUs
05 September 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), today announced that the
Read More